Skip to main content
. 2021 Jul 28;43(4):1024–1032. doi: 10.1038/s41401-021-00738-w

Fig. 1. Design and optimization of indomethacin derivatives for advanced prostate cancer.

Fig. 1

Structure of indomethacin derivatives and their half-maximum inhibitory concentration (IC50) values on CRPC C42B cell survival.